API australian pharmaceutical industries limited

We expect API to achieve strong earnings growth in FY07...

  1. 11,457 Posts.
    lightbulb Created with Sketch. 93
    We expect API to achieve strong earnings growth in FY07 following a period of restructuring and consolidation. In our view this outlook is not reflected in the current share price, with the stock trading on a low forward PE multiple and high, fully franked dividend yield. The key medium term risk to our forecasts is a major retail slowdown, which we see as unlikely. We view the current negative sentiment towards API as excessive and believe the stock currently represents very good value
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.